Top Markets
Coin of the day
Taysha Gene Therapies, Inc. Taysha Gene Therapies, Inc.

Taysha Gene Therapies, Inc.

TSHA
Ранг среди акций #6654
Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and... Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and market introduction of gene therapies that utilize adeno-associated virus (AAV) vectors. Its core mission is to tackle inherited diseases affecting the central nervous system (CNS). The company's development pipeline features several key programs: TSHA-120 is aimed at giant axonal neuropathy; TSHA-102 is in development for Rett syndrome; TSHA-121 and TSHA-118 are both being advanced for CLN1 disease; TSHA-105 addresses SLC13A5 Deficiency; and TSHA-101 targets GM2 gangliosidosis. Furthermore, Taysha has forged a strategic alliance with The University of Texas Southwestern Medical Center to jointly advance and bring to market innovative gene therapy solutions. Founded in 2019, the company operates from its headquarters in Dallas, Texas.
Цена акции
$6.02
Последняя синхронизация: 2026-08-27
Рыночная капитализация
$1.93B
Изменение (1 день)
0.00%
Изменение (1 год)
112.72%
Страна
US
Торговля Taysha Gene Therapies, Inc. (TSHA)

Категория

История дроблений акций Taysha Gene Therapies, Inc. (TSHA)
Акции Taysha Gene Therapies, Inc. (символ: TSHA) прошли через 0 дроблений.
Последнее дробление произошло Aug 28, 2026.
Одна акция TSHA, купленная до Aug 28, 2026, сейчас соответствует 0 акциям TSHA.
Список дроблений акций
Год Дробление Коэффициент Суммарный коэффициент
Недостаточно данных для указанных дат.
Дробления акций аналогичных компаний или конкурентов
Компания Количество дроблений акций Суммарный коэффициент Страна
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH